17-Hydroxyprogesterone

Test Code

HYD

Quest Code

17180

Alias/See Also

17OH PROGESTERONE

CPT Codes
83498

Preferred Specimen

0.5 mL serum collected in a red-top tube (no gel)

Minimum Volume

0.25 mL

Other Acceptable Specimens

Plasma collected in EDTA (lavender-top), or EDTA (royal blue-top), or sodium heparin (green-top), lithium heparin (green-top) tube

Instructions

Separate serum after clotting. Ship serum refrigerated or frozen.

Transport Temperature

Refrigerated (cold packs)

Specimen Stability

Room temperature: 48 hours
Refrigerated: 7 days
Frozen: 2 years

Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)

Gross hemolysis • Serum separator tube

Methodology
Chromatography/Mass Spectrometry

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by the U.S. Food and Drug Administration. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule

Set up: Daily; Report available: 2-5 days

Reference Range

Adult Males

18-30 years	32-307 ng/dL
31-40 years	42-196 ng/dL
41-50 years	33-195 ng/dL
51-60 years	37-129 ng/dL

Adult Females

Pre-Menopausal Mid Follicular	23-102 ng/dL
Pre-Menopausal Surge	67-349 ng/dL
Pre-Menopausal Mid Luteal	139-431 ng/dL
Postmenopausal Phase	≤45 ng/dL

Pregnancy

First Trimester	78-457 ng/dL
Second Trimester	90-357 ng/dL
Third Trimester	144-578 ng/dL

Pediatric

Cord Blood**	1000-3000 ng/dL
Premature Infants** (31-35 weeks)	≤405 ng/dL
Term Infants (12 hrs)**	<460 ng/dL
Values decline gradually to prepubertal levels

Male and Female
<30 days	Not established
1-11 months	≤147 ng/dL
1 year	≤139 ng/dL
2 years	≤134 ng/dL
3 years	≤131 ng/dL
4 years	≤131 ng/dL
5 years	≤133 ng/dL
6 years	≤137 ng/dL
7 years	≤145 ng/dL
8 years	≤154 ng/dL
9 years	≤166 ng/dL
10 years	≤180 ng/dL
11 years	≤196 ng/dL
12 years	≤213 ng/dL
13 years	≤233 ng/dL
14 years	≤254 ng/dL
15 years	19-276 ng/dL
16 years	23-300 ng/dL
17 years	26-325 ng/dL

Tanner Stages**

II-III Males	12-130 ng/dL
II-III Females	18-220 ng/dL
IV-V Males	51-190 ng/dL
IV-V Females	36-200 ng/dL

**Includes data from J Clin Endocrinol Metab.1991;73:674-686; J Clin Endocrinol Metab. 1989; 69:1133-1136; and J Clin Endocrinol Metab. 1994; 78:266-270. Pediatr Res 1988;23:525-529. MedLinePlus (accessed 6/16/14).

Clinical Significance

17-Hydroxyprogesterone is elevated in patients with Congenital Adrenal Hyperplasia (CAH). CAH is a group of autosomal recessive diseases characterized by a deficiency of cortisol and an excess of ACTH concentration. 17-Hydroxyprogesterone is also useful in monitoring cortisol replacement therapy and in evaluating infertility and adrenal and ovarian neoplasms.

Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly, VA 20153

The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.